Join a roundtable discussion by partners from the Securities Litigation, Enforcement, and White-Collar Criminal Defense practice group,
discussing the risks that life sciences companies face from private and government enforcement of securities law. Each panelist will discuss
practical ways to recognize and reduce your company’s and your personal exposure.

Topics will include:

• What risks do life science companies face from the SEC, the DOJ, and the class-action plaintiffs?
• Why are life science companies a target for private securities class actions?
• Why have the SEC- and the DOJ-targeted companies regulated by the FDA?
• Does your company have an adequate plan to address the Foreign Corrupt Practices Act?
• How can you reduce your personal exposure?
  

Experienced partners within the Securities Litigation, Enforcement, and White-Collar Defense Group of Morrison & Foerster will address these and additional subjects in a roundtable discussion. Our firm is a leading provider of legal services to biotechnology, pharmaceutical, and medical device companies around the nation. Each of the panelists will discuss recent developments and provide specific advice on how to address the risks to you and your company face from private and government enforcement of securities laws.

Who Should Attend:
Senior Management, Corporate Directors & Officers, Regulatory and Compliance Officers and In-House Counsel

There is no charge to attend this event.